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Material and Methods: We identified twenty-five 
glioblastoma patients treated with helical IMRT 
(Tomotherapy) with concurrent and adjuvant temozolamide 
between October 2011 and December 2013 from our 
radiotherapy electronic database and conducted a 
retrospective analysis. Hippocampi were contoured in CT and 
MRI co-registered image data sets used for clinical 
radiotherapy planning and hippocampus planning risk volumes 
(PRV) were created by adding five-millimetre isotropic 
margin which were checked by a neuro radiologist. Clinical 
treatment dosimetry plans were overlaid to obtain dose 
statistics. Four selected patients were planned for 
hippocampus avoidance radiotherapy without compromising 
tumour PTV coverage using currently established 
hippocampus dose volume histogram (DVH) constraints.  
 
Results: Mean hippocampus PRV maximum, minimum and 
mean radiation doses were 54.7, 24.15 and 38.62 Gy 
respectively. Hippocampus PRV V7.3, V14.9 and V20 were 
99.95%, 98.41% and 95.72% and hippocampus V3 was 100%. In 
seventeen patients ipsilateral hippocampus was within PTVs 
and in seven patients both hippocampi were outside PTVs 
with only minimal overlapping volumes but DVH based dose 
constraints were not achieved.  
 
 
With hippocampus avoidance planning (HA), in four patients 
hippocampus PRV minimum doses and in 3 patients mean 
hippocampus PRV doses were reduced and significant 
reductions in DVH based dose constraints were achieved in 3 
patients when compared to clinical treatment plans (table).  
 
Conclusion: Our analysis showed hippocampus PRVs received 
significant radiation doses and currently established 
hippocampus DVH based dose constraints were not achieved 
during cranial radiotherapy for glioblastoma using helical 
IMRT without hippocampus avoidance planning. Our planning 
study demonstrated significant dose reductions were possible 
with hippocampus avoidance radiotherapy planning in 
selected patients. More clinically correlated DVH objectives 
for hippocampus are required for better optimisation for 
hippocampus avoidance cranial radiotherapy in glioblastoma 
for this to be considered for all patients.  
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Purpose or Objective: To provide a comparison of 6 
different treatment planning strategies, adopted for breast 
conserving-adjuvant RT, on the dose to the PTV and OARs. 
 
Material and Methods: 22 patients CT data sets were 
retrospectively used for planning comparison. Patients were 
split in two groups of 6 left- and 5 right-sided cases (G1 and 
G2) according to the different dose prescription (50 Gy in 25 
fractions and 42.4 Gy in 16 fractions for G1 and G2, 
respectively). The 6 techniques involved were: Field in Field 
(FiF), 2 Fields static-IMRT (sIMRT-2ff), 4 Fields static-IMRT 
(sIMRT-4FF), VMAT, Helical Tomotherapy (HT) and Tomo 
Direct (TD). Dose limits applied to PTV and OARs were taken 
from the RTOG protocol n.1005. Treatments plans were 
optimized to reduce dose to Ipsilateral Lung (IL), 
Contralateral Breast (CB) and, for left-sided cases, Heart (H) 
while maintaining an acceptable PTV coverage and 
homogeneity. The Wilcoxon matched-paired signed-rank test 
was used to compare the results. The threshold for statistical 
significance was p≤0.05.  
 
Results: The highest mean value V95%=98.8%/99.2% (G1/G2) 
was observed for TD and it was statistically significant with 
respect to all others techniques except to VMAT. Similar 
results were obtained for D98%. The lowest mean 
V105%=0.2%/0.1% (G1/G2) was found for HT resulting 
statistically significant if compared to all other techniques 
except FIF/VMAT in G1 /G2, respectively. Mean D2% was also 
found lowest for HT (52.1Gy/43.1Gy in G1/G2) resulting 
statistically significant with respect to all other techniques 
except versus TD in G2. For IL mean V5(Gy), V10(Gy) and 
dose mean were lowest for TD in both groups (20.1%/19.1%, 
14.2%/13% and 5.8%/4.9% in G1/G2, respectively) being 
statistically significant versus all other techniques in G1. The 
lowest values of mean V20(Gy)=7.0%/7.9% were observed for 
HT in both groups. CB dose maximum was found as lowest in 
G1 for TD (290.9cGy) and for FiF in G2 (252,6cGy) both 
resulting statistically significant versus all other techniques 
except for FiF in G1 and TD in G2 confirming a substantial 
equivalence for the two techniques. Minor absolute dose 
differences were observed for H.  
 
Conclusion: 6 different techniques were employed to design 
an optimal plan for conserving breast-adjuvant RT fulfilling 
the dose limit criteria provided by RTOG 1005 protocol. TD 
provided superior target coverage maintaining a level of 
homogeneity similar to HT which achieved the highest value. 
IL dose was minimized with TD while dose to CB was lowest 
using both FiF and TD techniques.  
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Purpose or Objective: Preoperative Radiotherapy (RT) may 
theoretically improve resectability in locally advanced 
pancreatic cancer. However, effective doses of RT are 
limited by the tolerance of surrounding tissues. Stereotactic 
radiotherapy (SRT) with intensity-modulated technique 
(IMRT) based on the use of a Simultaneous Integrated Boost 
may theoretically allow to deliver a low dose to the 
duodenum (site of more common toxicity) and a high dose to 
the vessel invasion (more common reason of unresectability). 
Aim of this study was to perform a planning feasibility 
analysis of a modulated dose prescription within a pancreatic 
tumor treated by SRT. 
 
Material and Methods: 15 patients with a histological 
confirmation of pancreatic head adenocarcinoma with 
vascular involvement were included. The following 
definitions for targets were used: duodenal PTV (PTVd) was 
defined as the GTV overlapping the duodenal planning at risk 
volume (PRV) (from the pylorus to the duodenojejunal 
junction adding 5 mm in craniocaudal direction (CC), 3 mm in 
the other directions); vascular CTV (CTVv) was defined as the 
surface of contact or infiltration between tumor and vessel 
plus 5 mm margin around the vessel (including the whole 
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circumference of the vessel). The vascular PTV (PTVv) was 
considered as the CTVv plus an anisotropic margin (5 mm CC, 
3 mm in other directions). The tumor PTV (PTVt) was defined 
as the GTV plus an anisotropic margin (5 mm CC, 3 mm in 
other directions) including the PTVv and excluding the PTVd. 
The following doses were prescribed [in 5 daily fractions (fr)] 
to the PTVs: 30 Gy (6 Gy/fr) to the PTVd, 45 Gy (9 Gy/fr) to 
the PTVv, and 37.5 Gy (7.5 Gy/fr) to the PTVt, respectively. 
Constraints were based on AAPM TG101 recommendations: 
Dmax of PRVduodenum < 32.0 Gy, Dmax of PRVspinal cord < 
30.0 Gy, Dmax of PRVstomach < 32.0%, D700cc liver < 21.0 
Gy, D200 cc kidneys < 17.5 Gy. All plans were generated with 
Masterplan Oncentra TPS and the treatment was delivered 
with a step and shot IMRT technique. The primary end point 
was the rate of patients in whom the constraint Dmean > 90% 
was achieved for the 3 different PTVs. Secondary end points 
were the percentage of patients in whom a PTVv near 
minimum dose (D98%) > 90%, a PTVv D95% > 95%, and a 
median dose (D50%) > 95% were achieved. 
 
Results: PTVv Dmean > 90%, PTVv D2% < 115% and OARs Dmax 
constraints were achieved in all patients. Both PTVv D98% > 
90% and PTVv D95% > 95% were achieved in 6 patients (40%). 
 
Conclusion: Although the objective of PTVv D95% > 95% was 
achieved only in 40% of patients, the study showed that in 
100% of patients it was possible to administer a strongly 
differentiated mean and median dose, and in particular a low 
dose to the overlap region between the target and 
duodenum, a high dose to the site of vascular infiltration, 
and an intermediate dose to the remaining target volume. 
Prospective trials based on clinical application of this 
strategy seems to be justified at least in selected patients. 
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Purpose or Objective: Whole breast irradiation is part of 
breast conservative management for early breast cancer. In 
addition to that boost dose to tumor bed improves local 
recurrence rates and is currently the standard of care. Our 
aim of the current study was to evaluate intensity modulated 
radiation therapy (IMRT) for whole breast versus its 
dosimetric properties of volumetric modulated arc therapy 
(VMAT). 
 
Material and Methods: Eighteen consecutive women with left 
sided breast cancer were taken for this retrospective study. 
IMRT treatment plans were created for patients who already 
received treatment with VMAT. The plans were created in 
Monaco planning system using Monte Carlo (MC) algorithm. 
The Elekta Infinity linear accelerator with Agility MLC is used 
for VMAT delivery. Our clinic uses simultaneous integrated 
boost (SIB) technique to treat whole breast patients. The 
dose prescribed was 60Gy/25# to tumor bed and 45Gy/25# 
for whole breast. The plans were evaluated based on 
QUANTTEC dose-volume protocol. Data were statistically 
analyzed using Wilcoxon Signed Rank test. 
 
Results: VMAT technique statistically significant in target 
coverage and dose conformity than IMRT. In addition to that 
lesser ipsilateral & contra lateral lung dose and reduced 
contra lateral breast dose with VMAT. Critical structures like 
Left descending artery(LAD), Spinal Cord and heart also 
received lower doses with VMAT than IMRT . All the 
dosimetric parameters and its statistical values were 
provided in table1.Statistics shows VMAT more significant for 
LAD, Ipsilateral lung dose and Conformity Index. 
 
 
 
Conclusion: From this study , we infer that, our switch over 
from IMRT to VMAT treatment technique provided better 
dosimetric effect for left sided breast cancer patients. Also 
VMAT provided significant improvement target coverage and 
conformity. It reduced the dose to normal tissues further to 
IMRT. 
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Purpose or Objective: To estimate and compare the risk of 
radiation-induced hepatic toxicity (RIHT) in helical 
tomotherapy and fixed-beam intensity-modulated 
radiotherapy (IMRT) for the treatment of hepatocellular 
carcinoma (HCC). 
 
Material and Methods: Twenty patients with unresectable 
HCC treated with tomotherapy were selected. We performed 
tomotherapy re-planning to reduce the non-target normal 
liver volume receiving a dose of more than 15 Gy (NTNL-
V15Gy), and we created a fixed-beam IMRT plan (FB-P). We 
compared the dosimetric results as well as the estimated 
probability of RIHT among the tomotherapy initial plan (T-IP), 
the tomotherapy re-plan (T-RP), and the FB-P. 
 
Results: Comparing the T-RP and FB-P, the homogeneity 
index was 0.11 better with the T-RP. However, the mean 
NTNL-V15Gy was 6.3% lower with the FB-P. These differences 
result in a decline in the probability of RIHT from 0.216 in 
the T-RP to 0.115 in the FB-P. In patients whose NTNL-V15Gy 
was higher than 43.2% with the T-RP, the probability of RIHT 
markedly reduced from 0.533 to 0.274. 
 
